Surgical margins in the treatment of nonmelanoma skin cancer and Mohs micrographic surgery

Current Surgery

Volumn 62, Issue 5, 2005, Pages 518-526

  Lane, Joshua E ^a,b   Kent, David E ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Basal cell carcinoma; Mohs micrographic surgery; Nonmelanoma skin cancer; Squamous cell carcinoma; Surgical excision; Surgical margins

Indexed keywords

ACCURACY; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CHEMOSURGERY; FROZEN SECTION; HIGH RISK PATIENT; HUMAN; INTRAOPERATIVE PERIOD; MELANOMA; PATHOLOGIST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SURGEON; SURGICAL APPROACH; SURGICAL TECHNIQUE; TISSUE SECTION; TREATMENT INDICATION; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MOHS SURGERY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 23944462609     PISSN: 01497944     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cursur.2005.01.003     Document Type: Article

References (48)

1. Robinson JK. Mohs micrographic surgery. Clin Plast Surg. 1993;20:149-156
2. Miller SJ. The impact of non-melanoma skin cancer. J Nat Comp Cancer Net. 2004;2:2
3. Zak-Prelich M, Narbutt J, Sysa-Jedrzejowska A. Environmental risk factors predisposing to the development of skin cancer. Dermatol Surg. 2004;30:248-252
4. Housman TS, Williford PM, Feldman S, et al. Nonmelanoma skin cancer: An episode of care management approach. Dermatol Surg. 2003;29:700-711
5. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48: 425-429
6. Chen JG, Feldman SR, Fleischer AB, Yu G, Smith ED, Williford PM. The cost of nonmelanoma skin cancer management in the U.S. Medicare population. Dermatol Surg. 2001;27:1035-1038
7. Strom SS, Yamamura Y. Epidemiology of nonmelanoma skin cancer. Clin Plast Surg. 1997;24:627-636
8. Raszewski RL, Guyuron B. Long-term survival following nodal metastases from basal cell carcinoma. Ann Plast Surg. 1990;24:170-175
9. Christian MM, Murphy CM, Wagner RF. Metastatic basal cell carcinoma presenting as unilateral lymphedema. Dermatol Surg. 1998;24:1151-1153
10. Berti JJ, Sharata HH. Metastatic basal cell carcinoma to the lung. Cutis. 1999;63:165-166
11. Lund HZ. How often does squamous cell carcinoma of the skin metastasize? Arch Dermatol. 1965;92:635-637
12. Khurana VG, Mentis DH, O'Brien CJ, Hurst TL, Stevens GN, Packham NA. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg. 1995;170:446-450
13. Tavin E, Persky M. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope. 1996;106:156-158
14. Bucur A, Stefanescu L. Management of patients with squamous cell carcinoma of the lower lip and neck. J Craniomaxillofac Surg. 2004;32:16-18
15. Weinstock MA. Epidemiologic investigation of nonmelanoma skin cancer mortality: The Rhode Island Follow- Back Study. J Invest Dermatol. 1994;102:6S-9S
16. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146:1-6
17. Halder RM, Bridgeman-Shah S. Skin cancer in African-Americans. Cancer. 1995;75:667-673
18. Halder RM, Bang KM. Skin cancer in blacks in the United States. Derm Clin. 1988;6:397-405
19. Mora RG, Perniaciaro C, Lee B. Cancer of the skin in blacks: A review of nineteen black patients with Bowen's disease. J Am Acad Dermatol. 1984;11:557-562
20. Chu A, Osguthorpe JD. Nonmelanoma cutaneous malignancy with regional metastasis. Otolaryngol Head Neck Surg. 2003;128:663-673
21. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976-990
22. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;26: 1-26
23. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med. 1992;327:1649-1662
24. Bowman PH, Ratz JL, Knoepp TG, Barnes CJ, Finley EM. Basosquamous carcinoma. Dermatol Surg. 2003;29: 830-832
25. Niazi ZB, Lamberty BJ. Perineural infiltration in basal cell carcinomas. Br J Plast Surg. 1993;46:156-157
26. Terashi H, Kurata S, Tadokoro T, et al. Perineural and neural involvement in skin cancers. Dermatol Surg. 1997; 23:259-264
27. Ratner D, Lowe L, Johnson TM, Fader DJ. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer. 2000;88:1605-1613
28. Goepfert H, Dichtel WJ,Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell carcinoma of the head and neck. Am J Surg. 1984;148:542-547
29. Freeman RG. Handling of pathologic specimens for gross and microscopic examination in dermatologic surgery. J Dermatol Surg Oncol. 1982;8:673-679
30. Abide JM, Nahai F, Bennett RG. The meaning of surgical margins. Plast Reconstr Surg. 1984;73:492-496
31. Bennett RG. The meaning and significance of tissue margins. Adv Dermatol. 1989;4:343-355
32. Rapini RP. Comparison of methods for checking surgical margins. J Am Acad Dermatol. 1990;23:288-294
33. Sachs W, Sachs PM, Atkinson SC. Peripheral, or five point, method of skin biopsy. JAMA. 1950;142:902-903
34. Davidson TM, Nahum AM, Haghighi P, et al. The biopsy of head and neck cancer. Arch Otololaryngol. 1984;11:193
35. Hruza GJ. Mohs micrographic surgery. Otolaryngol Clin North Am. 1990;23:845-864
36. Swanson NA. Mohs surgery. Arch Dermatol. 1983;119: 761-773
37. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF. Mohs micrographic surgery. J Am Acad Dermatol. 1998; 39:79-97
38. Zalla MK, Lim KK, DiCaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg. 2000;26:771-784
39. Zachary CB, Rest EB, Furlong SM, Arcedo PN, McGeorge BC, Kist DA. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol. 1994;20: 530-535
40. Ramnarain ND, Walker NP, Markey AC. Basal cell carcinoma: Rapid techniques using cytokeratin markers to assist treatment by micrographic (Mohs') surgery. Br J Biomed Sci. 1995;52:184-187
41. Jimenez F, Clark FE, Buchanan MD, Kamino H. Lymphoepithelioma-like carcinoma of the skin treated with Mohs micrographic surgery in combination with immune staining for cytokeratins. J Am Acad Dermatol. 1995;32: 878-881
42. Jimenez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical techniques in Mohs micrographic surgery: Their potential use in the detection of neoplastic cells masked by inflammation. J AmAcad Dermatol. 1995; 32:89-94
43. Cook J, Zitelli JA. Mohs micrographic surgery: A cost analysis. J Am Acad Dermatol. 1998;39:698-703
44. Robins P. Chemosurgery: My 15 years of experience. J Dermatol Surg Oncol. 1981;7:779
45. Rowe DE, Carroll RJ, Day CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up. J Dermatol Surg Oncol. 1989;15:315
46. Menn H, Robins P, Kopf AW, et al. The recurrent basal cell epithelioma. Arch Dermatol. 1971;103:628
47. Rowe DE, Carroll RJ, Day CL. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15:424
48. Lang PG, Osguthorpe JD. Indications and limitations of Mohs micrographic surgery. Dermatol Clin. 1989;7:627-644